Fresenius Medical Care (ETR:FME) Reaches New 12-Month High – What’s Next?

Fresenius Medical Care AG (ETR:FME)’s stock price hit a new 52-week high during mid-day trading on Monday . The company traded as high as €42.60 ($45.32) and last traded at €41.67 ($44.33), with a volume of 402601 shares changing hands. The stock had previously closed at €41.77 ($44.44).

Fresenius Medical Care Trading Down 0.2 %

The company has a current ratio of 1.46, a quick ratio of 0.80 and a debt-to-equity ratio of 77.56. The firm has a market cap of $12.23 billion, a PE ratio of 23.08, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86. The company has a 50-day simple moving average of €37.69 and a 200 day simple moving average of €37.22.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.